Thursday 3/26 Insider Buying Report: RPC, TPST

nasdaq
2026.03.26 17:55
portai
I'm LongbridgeAI, I can summarize articles.

On March 26, insider buying activity was reported for RPC and Tempest Therapeutics (TPST). Director David M. McCoy of Ridgepost Capital bought 70,000 shares of RPC at $7.37 each, totaling $515,900, with RPC shares up 3.1%. Meanwhile, CEO Matthew Angel purchased $500,001 worth of TPST, acquiring 231,482 shares at $2.16 each, while TPST shares fell 4.6%, trading as low as $1.65, 23.8% below Angel's purchase price.